WCG
SNY icon

Weaver Consulting Group’s Sanofi SNY Stock Holding History

Weaver Consulting Group’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-117
Closed -$6K – 775
2020
Q3 		$6K Hold
117
– – ﹤0.01% 666
2020
Q2 		$6K Hold
117
– – ﹤0.01% 640
2020
Q1 		$5K Hold
117
– – ﹤0.01% 570
2019
Q4 		$5K Hold
117
– – ﹤0.01% 622
2019
Q3 		$5K Hold
117
– – ﹤0.01% 607
2019
Q2 		$5K Hold
117
– – ﹤0.01% 590
2019
Q1 		$5K Buy
+117
New +$5.01K ﹤0.01% 1119

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weaver Consulting Group's SNY Position: Q4 2020 in Review

Weaver Consulting Group sold out of Sanofi (SNY) in Q4 2020, closing a stake of 117 shares — an estimated $6K sold.

Weaver Consulting Group first reported a position in SNY in Q1 2019 and held it in 7 quarters. The position peaked at $6K in Q3 2020. 602 funds tracked by Wall St. Rank hold SNY as of Q4 2020.

  • Weaver Consulting Group reported no remaining Sanofi position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 117 Sanofi shares in Q4 2020, an estimated $6K.
  • Weaver Consulting Group first reported a position in Sanofi in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Sanofi position peaked at $6K in Q3 2020.
  • 602 funds tracked by Wall St. Rank held Sanofi as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.